Genesis Cancer and Blood Institute and American Oncology Network Welcome Endocrinologist Dr. Daryl Burrows and Nurse Practitioner Natalie Brown, APRN

/in /by

Arkansas-based practice expands care with new endocrinology services

HOT SPRINGS, Ark., Jan. 21, 2026 – Genesis Cancer and Blood Institute (GCBI), a partner practice of American Oncology Network (AON), is pleased to announce the addition of Board-certified endocrinologist Daryl Burrows, MD, and advanced practice registered nurse Natalie Brown, APRN, expanding the practice’s services to now include endocrinology care for patients in the region.

The addition of Burrows and Brown introduces endocrinology services that were not previously available at Genesis Cancer and Blood Institute, allowing patients to receive specialized endocrine care alongside their oncology treatment in a single, community-based setting.

Dr. Burrows joins an experienced physician team that includes Drs. Timothy Webb, Robert Muldoon, Stephen “Fred” Divers, Lynn Cleveland, Lingyi Chen, Sunil Kakadia, Kristen Sager, Brad Baltz, Jim Chen, Tyler Fugere and Beau Hilton.

He earned his medical degree from the University of Arkansas for Medical Sciences in Little Rock, where he also completed an internal medicine residency and a fellowship in diabetes, endocrinology and metabolism. He is a member of the American Medical Association, the American College of Physicians, the American Association of Clinical Endocrinologists and the Endocrine Society.

“I am excited to join Genesis Cancer and Blood Institute and to help expand the care available to patients through the addition of endocrinology services,” said Dr. Burrows. “Providing comprehensive, patient-centered care close to home is essential, and this new service allows patients to access specialized endocrine treatment within the same trusted community practice.”

Genesis Cancer and Blood Institute also welcomed Natalie Brown, APRN to its advanced practitioner team. She earned a Master of Science in Nursing from the University of Central Arkansas in Conway and has nearly 15 years of nursing experience, including 10 years in endocrinology.

With 11 medical oncologists, one endocrinologist, and six advance practice providers across 11 locations in Arkansas, Genesis Cancer and Blood Institute offers comprehensive cancer care, including diagnosis, treatment, clinical trials, survivorship and patient support. The addition of endocrinology services further enhances the practice’s ability to deliver coordinated, whole-patient care close to home.

“We are pleased to welcome Dr. Burrows and Natalie Brown to Genesis and to introduce endocrinology services for our patients,” said Robert Muldoon, MD, PhD. “Their expertise significantly expands the care we can provide and reflects our commitment to meeting more of our patients’ needs within our community.”

“Expanding access to specialized services like endocrinology is a meaningful step forward for patients,” said Stephen “Fred” Divers, MD, medical oncologist at Genesis and AON’s chief medical officer. “Dr. Burrows and Natalie Brown strengthen Genesis’ care team and support AON’s mission to deliver high-quality, patient-first community care.”

Burrows and Brown are now seeing patients at the Genesis Hot Springs—Higdon Ferry clinic.

For more information about American Oncology Network, visit AONcology.com. To learn more about Genesis Cancer and Blood Institute, visit genesiscancerblood.com.

About Genesis Cancer and Blood Institute

Specializing in the diagnosis and treatment of cancer and hematology, Genesis Cancer and Blood Institute (GCBI) is recognized for providing expert cancer care in Arkansas. The highly trained physicians, clinicians and staff are committed to ensuring the best possible outcomes for their patients. The medical oncology/hematology physicians at Genesis Cancer and Blood Institute include Dr. Brad Baltz, Dr. Jim Chen, Dr. R. Timothy Webb, Dr. Robert T. Muldoon, Dr. Stephen “Fred” Divers, Dr. A. Lynn Cleveland, Dr. Lingyi Chen, Dr. Sunil Kakadia, Dr. Kristen Sager, Dr. Tyler Fugere, Dr. Beau Hilton. The practice also includes Endocrinologist, Dr. Daryl Burrows. Learn more at genesiscancerblood.com.

About American Oncology Network

American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

American Oncology Research and MiBA Form Strategic Alliance to Integrate Real-Time Data Intelligence with Community-Based Clinical Research

/in /by

FORT MYERS, Fla. – Jan. 14, 2026 – – American Oncology Research, LLC (AOR), and Meaningful Insights Biotech Analytics, LLC (MiBA), today announced a strategic partnership designed to align operational infrastructure with advanced data intelligence in community oncology. By integrating AOR’s site management capabilities with MiBA’s AI-enhanced data ecosystem, the alliance creates a unified framework that closes gaps between study design, site feasibility and patient access.

The collaboration addresses a longstanding challenge in the pharmaceutical industry: the disconnect between static clinical trial protocols and the dynamic reality of patient care. By embedding intelligent data workflows directly into the American Oncology Network (AON), the partnership aims to shift clinical research from a reactive administrative process to a proactive, data-informed discipline.

“To truly advance patient care, we must modernize the infrastructure that supports it,” said Katie Goodman, vice president of research at American Oncology Research. “Our partnership with MiBA moves beyond traditional site management by operationalizing real-time data. This allows us to identify friction points before they occur—whether in feasibility, startup or enrollment—ensuring that the speed of research matches the urgency of our patients’ needs.”

Optimizing the Research Lifecycle 

The alliance focuses on reducing the timeline between site selection and patient enrollment. By leveraging MiBA’s deep Real-World Data (RWD) capabilities, AOR can conduct feasibility analysis and patient matching based on contemporaneous network data. This provides a near-real-time view of eligible patient populations, enabling research teams to validate site viability and mobilize resources with greater precision. 

“Integrating real-time data into community research is essential to closing the gap between trial availability and patient need,” said Ralph V. Boccia, MD, medical director of American Oncology Research. “This partnership strengthens our ability to identify eligible patients sooner, open trials more efficiently and ensure that life-changing therapies are accessible to individuals receiving care close to home.”

“The future of clinical development relies on the seamless convergence of care and research,” said Mark Moch, managing partner at MiBA. “We are moving away from fragmented, siloed processes toward an integrated model where insights drive action. By embedding AI-powered intelligence into AOR’s clinical workflows, we are not just identifying patients; we are architecting a system where trials are accessible, efficient and aligned with the provider’s daily workflow.”

Enhancing Provider Engagement and Trial Equity

A key component of the strategy is the integration of research opportunities directly into the point of care. The platform uses targeted insights within the Electronic Medical Record (EMR) environment to close the awareness gap for oncologists, ensuring clinical trials are presented as immediate and viable care options rather than retrospective considerations.

The partnership also strengthens the industry’s ability to meet Diversity Action Plan (DAP) requirements. With a holistic, data-driven operational model, AOR can proactively identify demographic barriers and implement inclusive enrollment strategies during study design. This approach reduces the risk of costly protocol amendments and supports more representative, high-quality data generation.

###

About American Oncology Research (AOR)

American Oncology Research (AOR) helps practices offer cutting-edge clinical trials without added burden. As part of the American Oncology Network (AON), we bring proven expertise, tailored site management services, and advanced tools to local practices—so more patients can access promising treatments right in their own communities.

We partner with research sites to streamline trial operations, from regulatory oversight to patient recruitment, financial tracking, and beyond. Our approach simplifies processes for providers and accelerates access for patients—without compromising quality, compliance, or care.

With AOR, practices can launch or expand trial offerings and deliver innovation locally-shaping the future of cancer care one patient at a time.

About Meaningful Insights Biotech Analytics

Meaningful Insights Biotech Analytics (MiBA) is a healthcare AI technology company on a mission to close the feedback loop between physicians, patients, and industry partners. The technology and data insights that MiBA generates supports pharmaceutical companies, research organizations, payers, biotech, health systems and providers to advance the quality of patient care. Learn more at www.mibaanalytics.com.

About American Oncology Network

American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Lone Star Oncology and American Oncology Network Welcome Dr. Derrick Nguyen

/in /by

GEORGETOWN, Texas, Jan. 6, 2026 – Lone Star Oncology and American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices, is pleased to announce Derrick Nguyen, MD, FACP, has joined the practice’s physician team and is accepting new patients.

Dr. Nguyen is a Board-certified medical oncologist who has been practicing for over 15 years. He earned his Doctor of Medicine degree from the University of Texas Health Science Center at San Antonio.

Upon graduation, he completed an internal medicine internship and residency at the University of New Mexico Health Sciences Center in Albuquerque. He then completed a medical oncology fellowship at the University of Texas Health Science Center.

“I am honored to join Lone Star Oncology,” said Dr. Nguyen. “The practice has built a strong reputation for delivering compassionate patient-centered care close to home. That philosophy closely aligns with my own approach to oncology, and I look forward to working alongside Dr. Shimkus and the care team to serve patients and families in our community.”

“We are pleased to welcome Dr. Nguyen to Lone Star Oncology,” said Brian J. Shimkus, MD, a Board-certified medical oncologist and hematologist at the practice. “His clinical expertise and commitment to personalized care will further strengthen our ability to provide high-quality oncology services to the Central Texas patients we serve.”

Lone Star Oncology opened in June 2023 and joined AON at that time. The community-based oncology and hematology practice is led by Dr. Shimkus and his multidisciplinary care team and specializes in the treatment of cancer and blood disorders.

Through its partnership with AON, Lone Star Oncology has expanded access to services including infusion therapy, centralized laboratory and pathology services, oral oncolytic medication delivery and financial counseling.

“On behalf of American Oncology Network, I am pleased to welcome Dr. Nguyen to Lone Star Oncology and to our national network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “His dedication to compassionate, high-quality care reflects our mission to deliver exceptional, patient-centered cancer care in the communities where patients live and work. Dr. Nguyen will be a valuable addition to the team and to the patients we serve across Texas.”

For more information about American Oncology Network, visit  www.AONcology.com. For more information about Lone Star Oncology, visit www.lonestaronc.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Lone Star Oncology
Lone Star Oncology is a community-based medical oncology and hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. Through compassionate care that centers around the patient, we strive to provide the best possible experience to patients and their families throughout the healthcare journey. Learn more at www.lonestaronc.com.

Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Central Georgia Cancer Care Expands Macon Campus with New Stand-Alone PET/CT Imaging Building

/in /by

Macon, GA — Dec. 15, 2025 – Central Georgia Cancer Care (CGCC), a partner practice of American Oncology Network (AON), is proud to announce the opening of its new state-of-the-art PET/CT Imaging Building, located behind the Macon Clinic at 5430 Bowman Road. The addition represents another milestone in CGCC’s continued commitment to providing comprehensive, compassionate community cancer care in one convenient location close to where patients live and work.

Designed to enhance the patient experience and streamline care, the new facility offers advanced imaging technology in a private, patient-focused setting — allowing patients to complete imaging and consultations all in one visit. The new PET/CT Imaging Building also features:

  • A brand-new PET/CT machine equipped with the latest technology for precise and efficient imaging
  • Private intake rooms for each patient (three total), ensuring privacy and comfort throughout the process
  • Convenient on-site parking and direct access to patients’ oncologists and hematologists in the adjacent clinic
  • A non-hospital environment, reducing exposure risks for immunocompromised patients and providing a quieter, more personal care experience
  • Quicker, more flexible scheduling and faster scan turnaround times
  • Internal radiology review, ensuring consistency with one dedicated radiologist interpreting all scans
  • Cost savings and improved coordination of care through CGCC’s integrated oncology model

“This new PET/CT Imaging Building reflects our ongoing commitment to patient-centered care,” said Bradley T. Sumrall, M.D., managing partner and physician at Central Georgia Cancer Care. “Having imaging services right next door to our clinic means we can review results more quickly, collaborate seamlessly, and make timely decisions that directly impact patient outcomes — all while offering a more comfortable and convenient experience.”

The PET/CT Imaging Building further enhances the comprehensive range of services offered at CGCC, which opened its new main clinic earlier in the year. Together, these facilities position Central Georgia Cancer Care as a leader in community oncology care — offering the latest advancements in cancer diagnosis and treatment under one roof.

ABOUT CENTRAL GEORGIA CANCER CARE: Since 1977, Central Georgia Cancer Care (CGCC) has provided compassionate, high-quality care for patients with cancer and blood disorders throughout Central and South Georgia. As one of the few Georgia practices selected for the national Oncology Care Model, CGCC is also the only oncology center in the state to hold both QOPI® Certification and ASCO’s Patient-Centered Cancer Care Certification. Their board-certified physicians and care team provide innovative treatment close to home — supporting patients’ health and well-being at every step.

ABOUT AMERICAN ONCOLOGY NETWORK: American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

American Oncology Network Welcomes Robert J. McDonald, MD, FACNM, as Radiology Medical Director and In-House Reading Radiologist

/in /by

Dr. McDonald’s Role Supports AON’s Growth in Radiotheranostics and Network-Wide RLT Capabilities.

Fort Myers, FL – Dec. 10, 2025 – American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, is pleased to announce the addition of Robert J. McDonald, MD, FACNM – a nationally recognized, board-certified nuclear medicine physician – as Radiology Medical Director and in-house reading radiologist. In this role, Dr. McDonald will support AON’s strategic expansion of radiotheranostic services throughout the network and strengthen AON’s commitment to delivering cutting-edge cancer care close to where patients live and work.

Dr. McDonald will serve as the primary reading radiologist for AON partner practices Florida Oncology & Hematology (FOH) in Naples and Fort Myers, and Central Georgia Cancer Care (CGCC) in Macon, providing expert interpretations for PET and CT imaging. He will also perform advanced radiotheranostic therapies at the Naples and Fort Myers location, while overseeing radiology services as Medical Director at each practice he supports.

As AON continues to expand its radiotheranostic footprint, Dr. McDonald will play an integral role in developing physicians, supporting future program growth, and bringing advanced RLT treatment options to more AON practice sites in 2026. The Nuclear Regulatory Commission (NRC) requires new Authorized Users of radioligand therapies to complete clinical preceptorships, and part of Dr. McDonald’s position includes conducting these preceptorships on-site when needed, helping ensure safe, timely expansion of radioligand expertise across the network.

In addition, Dr. McDonald will lead clinical refinement of AON’s RLT protocols and assist in the adoption and rollout of newly FDA-approved radiotheranostic therapies – further positioning AON at the forefront of innovation in community oncology.

“AON is at the leading edge of radiotheranostics in community oncology, and Dr. McDonald’s expertise will accelerate our ability to bring groundbreaking radioligand treatments to more patients across the country,” said Todd Schonherz, AON chief executive officer. “His leadership in clinical training, protocol development, and program expansion will be essential as we scale radiotheranostic services to additional AON practice sites in 2026 and beyond. We are proud to welcome him and look forward to what his presence will make possible for our physicians, our practices, and the patients we serve.”

“Bringing Dr. McDonald into these roles allows us to enhance the quality, continuity, and cost-effectiveness of radiological services across our practices,” said Guy Messer, AON vice president of radiation and radiology services. “His expertise strengthens our ability to deliver timely imaging and treatment while also advancing the expansion of radiotheranostics within AON – a core element of our commitment to improving access to next-generation cancer care in community settings.”

Dr. McDonald joins AON with more than 30 years of experience in diagnostic imaging and radioligand therapies. He previously served as the Medical Director of Imaging Services for Florida Cancer Specialists & Research Institute, specializing in PET/CT interpretation and therapeutic nuclear medicine.

His career includes leadership appointments at MD Anderson Cancer Center Orlando, extensive work with Radiology Regional Center in Southwest Florida, and leadership positions in major medical centers in Oregon and California. He has also held multiple leadership roles within the Society of Nuclear Medicine & Molecular Imaging and is a Fellow of the American College of Nuclear Medicine.

Dr. McDonald is a respected researcher, educator, and speaker who has contributed to numerous clinical studies and national presentations advancing nuclear medicine. He earned his medical degree from the Medical College of Virginia and completed his nuclear medicine residency at the University of California Irvine Medical Center.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Hawai’i Cancer Care and American Oncology Network Open New Kahului Clinic

/in /by

Hawai’i-based community oncology practice opens third location, expanding cancer care access for Maui patients.

KAHULUI, Hawai’i, Dec. 2, 2025 —Hawai’i Cancer Care, a partner practice of American Oncology Network (AON), today announced its expansion in Hawai’i with the opening of a new clinic in Kahului. The addition of this location – at 17 La’a Street, Unit B – provides Maui residents with greater access to high-quality, patient-centered cancer care close to home.

Board-certified medical oncologists Dr. Melvin P. Palalay and Dr. David J. Tamura and nurse practitioner Judy Ko, RN, MSN, APRN are now accepting patients at the Hawai’i Cancer Care – Kahului clinic, which will be open on Tuesdays and Wednesdays.

The new location includes private exam rooms designed for patient-physician consultations and an infusion room. New and existing patients can call (808) 727-8341 for more information or to schedule an appointment.

“We’re excited to welcome patients to our new Kahului clinic, where they’ll receive the same exceptional, compassionate care we provide at all Hawai’i Cancer Care locations,” said Dr. Palalay. “Our patient-first approach guides everything we do, and we’re committed to maintaining the highest standards of care for every person who walks through our doors.”

With the opening of the Kahului clinic, Hawai’i Cancer Care now operates three locations across the state. The practice is dedicated to providing comprehensive, research-based treatment for cancer and blood disorders through a holistic, team-oriented approach. Patients benefit from a full range of services – from diagnosis and treatment to survivorship and support – without the need to travel long distances for care.

“This new clinic allows us to make high-quality cancer care more accessible to patients on Maui,” said Dr. Tamura. “We look forward to serving this community and continuing our mission to deliver personalized care that meets each patient’s unique needs.”

For more information about American Oncology Network, visit AONcology.com. To learn more about Hawai’i Cancer Care, visit hawaiicancercare.com.

About Hawai’i Cancer Care
Hawai’i Cancer Care is dedicated to providing individualized, precision-based cancer treatment and supportive care to patients across O’ahu and Maui. The physicians of Hawai’i Cancer Care have been serving cancer patients in Hawai’i for more than 20 years. Hawai’i Cancer Care’s multidisciplinary team of highly trained physicians and medical professionals delivers comprehensive care using the latest treatment procedures, advanced technology, and access to a broad range of clinical trial programs.

Hawai’i Cancer Care recognizes that healing extends beyond medicine, offering emotional and educational support to help patients and their families navigate every step of the cancer journey—close to home and surrounded by their support network. Guided by a commitment to excellence, compassion, and innovation, Hawai’i Cancer Care strives to deliver the best possible experience and outcomes for every patient. Learn more at hawaiicancercare.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden

/in /by

Evolent and AON logos

WASHINGTON, NOVEMBER 6, 2025 – Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, and American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, today announced a new model enabling high-quality, more affordable, and connected cancer care — all without relying on prior authorization.

The national partnership seeks to improve clinical decision-making by introducing quality-focused interventions, driving clinical insights through an innovative data and analytics platform, and rewarding providers for high-quality care. As providers demonstrate adherence to quality, they will be “gold-carded” — no longer required to seek authorization from payers for most tests and treatments. Meanwhile, Evolent intends to use its care navigation program to complement AON’s existing capabilities to help patients manage daily life with cancer and stay better connected to their oncology team. AON and Evolent expect to roll out this model in select markets in the year ahead.

“Community oncology practices are a linchpin of our cancer care system, but they face immense pressures, from administrative burdens and financial stresses to care coordination needs,” said AON Chief Medical Officer Dr. Stephen “Fred” Divers. “With its provider-centric approach and uncompromising focus on doing what is best for patients, Evolent is an ideal partner. Evolent’s quality efforts go beyond common strategies that are largely tapped out — like shifting to biosimilars — to tackle some of the major drivers of quality and costs in cancer care.”

Key components of the program include:

  • Quality initiatives. Evolent and AON will help providers act on high-impact but underused opportunities to improve quality and affordability across the full continuum of care beyond traditional utilization management. The partnership seeks to drive sustained quality improvement through a systematic approach that combines provider education, scorecards, automated reminders delivered directly in the electronic medical record, and incentives.
  • AI-driven clinical insights. The model is powered in part by MiBA (Meaningful Insights Biotech Analytics), an innovative data and analytics platform co-developed in collaboration with AON, that supports providers with evidence-based insights and personalized cancer treatment plans. Harnessing real-time data in the electronic health record, the platform uses analytics and algorithms to uncover patterns, trends and correlations that can improve patient care and drive innovation.
  • Payment innovation. AON and Evolent are developing an aligned payment model seeking to reward oncology practices for delivering high-quality care. Moving beyond traditional fee-for-service models, the model aims to re-wire incentives to encourage providers to select the clinically optimal drug regimen for each patient.
  • Eliminating prior authorization. Providers who adhere to high-quality treatment pathways will no longer need prior authorization for most tests and treatments. This should accelerate the time to treatment and reduce the administrative burden for practices and patients.
  • Care navigation. AON patients will have access to Evolent’s comprehensive cancer care navigation program, which combines personalized navigation and a cancer care management platform, Careology, to help patients move through their journey with greater confidence and support. AON and Evolent believe this program will bolster AON’s existing care management capabilities and support the goal of end-to-end condition management.

“Patients, providers and health plans want the same thing out of the cancer journey — longer survival and a higher quality of life without unnecessary costs or hassles,” said Evolent President Dan McCarthy. “Yet, traditional models create friction between these groups as well as gaps, resulting in misaligned care, provider burnout and administrative waste. We’re thrilled to collaborate with American Oncology Network, as another leader in high-value cancer care, to create an ecosystem in which everyone wins when patients receive the best possible care.”

About Evolent
Evolent (NYSE: EVH) specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting evolent.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Media inquiries

Evolent

Jamie Manfuso

media@evolent.com

American Oncology Network

Karen Riley Sawyer

Karen.Sawyer@AONcology.com

American Oncology Network Presents 15 Research Abstracts at ASCO Quality 2025

/in /by

FORT MYERS, Fla.—Oct. 10, 2025—American Oncology Network (AON), one of the fastest-growing community oncology networks in the nation, announced today that 15 research abstracts by AON physicians and leaders have been accepted for presentation at the American Society of Clinical Oncology (ASCO) Quality Care Symposium 2025. The event, themed Driving Solutions, Implementing Change, takes place Oct. 10-11 in Chicago.

AON leaders will present on a variety of topics including the Inflation Reduction Act’s influence on Enhancing Oncology Model (EOM) Part D expenditures and total cost of care (Abstract #2) and Inflation’s Toll on Oncology Physician Reimbursement (Abstract #21).

Physicians from American Oncology Network

A full list of AON physician and leader abstracts at the ASCO Quality Care Symposium include:

“It is an honor to share our research and latest findings with peers at ASCO’s Quality Care Symposium,” said Puneeth Indurlal, MD, AON’s senior vice president of strategic operations and co-author on all abstracts. “ASCO symposiums foster collaboration, innovation, and the advancement of clinical oncology. Our participation reflects our ongoing commitment to improving cancer care through evidence-based practices.”

“These studies – many in collaboration with our value-based care partner, Thyme Care – demonstrate the powerful combination of real-world clinical data and robust technology to harness it for the creation of value-based insights that will be used to improve community oncology today and tomorrow,” said Dr. Stephen “Fred” Divers, AON’s chief medical officer and co-author on all abstracts.

“Having so many AON physicians and leaders featured at ASCO’s Quality Care Symposium speaks volumes about the caliber of talent across our network,” said Todd Schonherz, AON’s chief executive officer and co-author on many abstracts. “We are proud that AON’s culture of innovation and learning is supporting ASCO in advancing the field of oncology.”

For more information about AON, visit AONcology.com.

About American Oncology Network

American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

American Oncology Network Appears on Health Uncensored with Dr. Drew to Discuss New Partnership with CanCare, Inc.

/in /by

American Oncology Network + CanCare, Inc. = Holistic Community Cancer Support

October 9, 2025: AON Vice President of Clinical Innovation, Susan Sabo-Wagner and Dr. Kodityal from AON partner practice Woodlands Cancer Institute were recently featured alongside CanCare Inc. President and CEO, Darcie Champagne Wells on Health Uncensored with Dr. Drew to discuss the new partnership between AON and CanCare.

AON brings state-of-the-art cancer care to patients across the nation through community oncology practices in their own neighborhoods where they live and work. And CanCare ensures cancer patients receive the emotional support they need from cancer diagnosis through remission and beyond – pairing them with volunteers who have been through a similar diagnosis to provide the support and comfort they need to get through what is often the most difficult time of their lives.

AON + CanCare = Holistic physical and emotional cancer care support for patients in their own communities across the nation.

We couldn’t be prouder of this partnership and this segment! Watch it here:

American Oncology Network and The Center for Cancer and Blood Disorders Welcome Dr. Chitra Rajagopal

/in /by

Board-certified medical oncologist joins AON’s CCBD physician team

BETHESDA, MD, Oct. 7, 2025 –  American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices, and its partner practice, The Center for Cancer and Blood Disorders (CCBD), today announced that medical oncologist Chitra Rajagopal, MD (“Dr. Raj”), has joined the physician care team. She will see patients in Germantown and Bethesda, Maryland, alongside the practice’s existing team of experienced providers.

Dr. Raj is Board-certified in medical oncology. She earned her medical degree from Stanley Medical College in Madras, India, where she graduated as the Best Outgoing Student. She completed her internship and residency in internal medicine at SUNY Downstate Medical Center in Brooklyn, followed by a fellowship in hematology and oncology and a subspecialty fellowship in bone marrow transplantation at Georgetown University Hospital’s Lombardi Cancer Center. Since 1997, she has provided comprehensive community-based cancer care, served as faculty at Georgetown University Hospital, and held leadership roles at Shady Grove Hospital. She has also been a member of the American Society of Clinical Oncology, the American Society of Hematology, the American College of Physicians, the American Medical Association, and the American Bone Marrow Transplant Registry.

“I am pleased to join The Center for Cancer and Blood Disorders,” said Dr. Raj. “This practice is well known for providing patient-centered, innovative care, and I am eager to contribute to its mission while caring for patients in our community.”

“We are thrilled to welcome Dr. Raj to our team,” said Ralph Boccia, MD, FACP, Medical Director and managing partner at CCBD. “Her dedication to evidence-based medicine and compassionate care will further enhance the high standard of service our patients have come to expect.”

“Dr. Raj brings a wealth of experience and commitment to excellence that aligns with AON’s mission,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Her expertise will be a tremendous asset to patients and providers across our Maryland network.”

CCBD provides community-based oncology services to patients in Bethesda, Germantown, and Baltimore, Maryland. The practice offers comprehensive cancer care, including diagnostics, cutting edge treatments, clinical trials that offer innovative opportunities, survivorship programs and patient support – all delivered close to home to reduce travel burdens for patients and their families. CCBD clinics feature private exam rooms and on-site infusion suites designed for patient comfort and privacy during treatment.

Dr. Raj is now seeing patients at CCBD’s Germantown and Bethesda locations. Germantown serves as her primary practice site, where she is currently available three days a week and will expand to four days a week beginning in January.

For more information about AON, visit AONcology.com. To learn more about The Center for Cancer and Blood Disorders, visit ccbdmd.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About The Center for Cancer and Blood Disorders
Specialists in the diagnosis and treatment of blood disorders and cancer, The Center for Cancer and Blood Disorders has been serving patients in the communities and surrounding areas of Bethesda, Germantown, and Baltimore, Maryland for more than 25 years. Their individualized approach to patient care includes chemotherapy, targeted therapy, immunotherapy and when appropriate, cutting-edge therapies on clinical trials. The practice regularly performs more than 300 clinical trials on new and developing diagnostic devices and techniques for cancer and diseases. Patients receive home delivery of oral cancer medications, in-house lab and pathology and on-site infusion therapy. The practice also offers comprehensive support with nutrition guidance and financial counseling. Learn more at ccbdmd.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com